Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.
Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Front Immunol. 2021 Sep 29;12:748097. doi: 10.3389/fimmu.2021.748097. eCollection 2021.
The SARS-CoV-2 infection [coronavirus disease 2019 (COVID-19)] is associated with severe lymphopenia and impaired immune response, including expansion of myeloid cells with regulatory functions, e.g., so-called low-density neutrophils, containing granulocytic myeloid-derived suppressor cells (LDNs/PMN-MDSCs). These cells have been described in both infections and cancer and are known for their immunosuppressive activity. In the case of COVID-19, long-term complications have been frequently observed (long-COVID). In this context, we aimed to investigate the immune response of COVID-19 convalescents after a mild or asymptomatic course of disease. We enrolled 13 convalescents who underwent a mild or asymptomatic infection with SARS-CoV-2, confirmed by a positive result of the PCR test, and 13 healthy donors without SARS-CoV-2 infection in the past. Whole blood was used for T-cell subpopulation and LDNs/PMN-MDSCs analysis. LDNs/PMN-MDSCs and normal density neutrophils (NDNs) were sorted out by FACS and used for T-cell proliferation assay with autologous T cells activated with anti-CD3 mAb. Serum samples were used for the detection of anti-SARS-CoV-2 neutralizing IgG and GM-CSF concentration. Our results showed that in convalescents, even 3 months after infection, an elevated level of LDNs/PMN-MDSCs is still maintained in the blood, which correlates negatively with the level of CD8 and double-negative T cells. Moreover, LDNs/PMN-MDSCs and NDNs showed a tendency for affecting the production of anti-SARS-CoV-2 S1 neutralizing antibodies. Surprisingly, our data showed that in addition to LDNs/PMN-MDSCs, NDNs from convalescents also inhibit proliferation of autologous T cells. Additionally, in the convalescent sera, we detected significantly higher concentrations of GM-CSF, indicating the role of emergency granulopoiesis. We conclude that in mild or asymptomatic COVID-19 convalescents, the neutrophil dysfunction, including propagation of PD-L1-positive LDNs/PMN-MDSCs and NDNs, is responsible for long-term endotype of immunosuppression.
SARS-CoV-2 感染(冠状病毒病 2019,COVID-19)与严重的淋巴细胞减少和免疫应答受损有关,包括具有调节功能的髓系细胞的扩增,例如所谓的低密度中性粒细胞,其中含有粒细胞髓系来源的抑制性细胞(LDN/PMN-MDSC)。这些细胞在感染和癌症中都有描述,以其免疫抑制活性而闻名。在 COVID-19 的情况下,经常观察到长期并发症(长 COVID)。在这种情况下,我们旨在研究轻度或无症状 COVID-19 恢复期患者的免疫反应。我们招募了 13 名曾感染 SARS-CoV-2 的恢复期患者,这些患者的感染经 PCR 检测呈阳性结果证实,且过去没有 SARS-CoV-2 感染。采集全血用于 T 细胞亚群和 LDN/PMN-MDSC 分析。通过 FACS 分选 LDN/PMN-MDSC 和正常密度中性粒细胞(NDN),并用抗 CD3 mAb 激活的自体 T 细胞进行 T 细胞增殖测定。血清样本用于检测抗 SARS-CoV-2 中和 IgG 和 GM-CSF 浓度。我们的结果表明,即使在感染后 3 个月,恢复期患者血液中仍维持着高水平的 LDN/PMN-MDSC,与 CD8 和双阴性 T 细胞的水平呈负相关。此外,LDN/PMN-MDSC 和 NDN 倾向于影响抗 SARS-CoV-2 S1 中和抗体的产生。令人惊讶的是,我们的数据表明,除了 LDN/PMN-MDSC 之外,恢复期患者的 NDN 也抑制自体 T 细胞的增殖。此外,在恢复期患者的血清中,我们检测到 GM-CSF 的浓度显著升高,表明紧急粒系生成的作用。我们得出结论,在轻度或无症状 COVID-19 恢复期患者中,中性粒细胞功能障碍,包括 PD-L1 阳性 LDN/PMN-MDSC 和 NDN 的增殖,是导致长期免疫抑制表型的原因。